<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epidemiologic data show that the immune system may control or promote the emergence and growth of neoplastic lymphomatous clones </plain></SENT>
<SENT sid="1" pm="."><plain>Conversely, systemic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, especially <z:mp ids='MP_0009440'>myeloma</z:mp> and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL), are associated with clinical <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This prospective controlled study demonstrates substantially <z:hpo ids='HP_0008165'>reduced circulating T helper cells</z:hpo>, predominantly naive CD4(+) cells, in patients with nonleukemic follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and extranodal marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, but not in <z:e sem="disease" ids="C1136085" disease_type="Neoplastic Process" abbrv="">monoclonal gammopathy</z:e> and early CLL </plain></SENT>
<SENT sid="3" pm="."><plain>These changes were correlated with a preactivated phenotype, hyperreactivity in vitro, pre-senescence, and a T helper 2 shift of peripheral T helper cells </plain></SENT>
<SENT sid="4" pm="."><plain>No prominent alterations existed in the regulatory T-cell compartment </plain></SENT>
<SENT sid="5" pm="."><plain>Gene expression profiling of in vitro-stimulated CD4(+) cells revealed an independent second alteration of T helper cell <z:mp ids='MP_0001532'>physiology</z:mp>, which was most pronounced in early CLL but also detectable in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/extranodal marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>This pattern consisted of down-regulation of T-cell receptor signaling cascades and globally reduced cytokine secretion </plain></SENT>
<SENT sid="7" pm="."><plain>Both types of <z:hpo ids='HP_0005435'>T-cell dysfunction</z:hpo> may contribute to significant <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> in nonleukemic indolent B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> as demonstrated by unresponsiveness to <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B vaccination </plain></SENT>
<SENT sid="8" pm="."><plain>The precise definition of systemic <z:hpo ids='HP_0005435'>T-cell dysfunction</z:hpo> serves as the basis to study its prognostic impact, its relationship to the established influence of the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> microenvironment, and its therapeutic manipulation </plain></SENT>
</text></document>